Sartorius Stedim Biotech annual debt-to-equity ratio
2020
2021
2022
2023
2024
2025
Sartorius Stedim Biotech Debt-to-Equity Ratio Growth & History (DIM)
Sartorius Stedim Biotech's debt-to-equity ratio was 0.64 for fiscal 2025.
View full Sartorius Stedim Biotech company overviewSartorius Stedim Biotech annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.64 | −0.08 | −11.72% |
| 2024 | 2024-12-31 | 0.72 | −0.68 | −48.42% |
| 2023 | 2023-12-31 | 1.40 | 0.93 | +200.95% |
| 2022 | 2022-12-31 | 0.46 | 0.09 | +22.75% |
| 2021 | 2021-12-31 | 0.38 | −0.03 | −7.47% |
| 2020 | 2020-12-31 | 0.41 | — | — |
Sartorius Stedim Biotech quarterly debt-to-equity ratio
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.57 | −0.17 | −23.54% |
| Q1 2026 | 2026-03-31 | 0.64 | −0.10 | −13.80% |
| Q4 2025 | 2025-12-31 | 0.64 | — | — |
| Q2 2025 | 2025-06-30 | 0.74 | — | — |
| Q1 2025 | 2025-03-31 | 0.74 | — | — |
Sartorius Stedim Biotech debt-to-equity ratio trends
Over the last five fiscal years, Sartorius Stedim Biotech's debt-to-equity ratio increased from 0.41 to 0.64, a change of 0.23. The latest reported quarter, Q2 2026, shows 0.57.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sartorius Stedim Biotech source filings ↗